Grazax Placebo

BIOLOGICAL2 trials

Sponsors

ALK-Abelló A/S, Imperial College London

Conditions

Allergic RhinitisAllergy

Phase 2

Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study

CompletedNCT02005627

Imperial College LondonAllergic Rhinitis

Start: 2013-09-01End: 2017-03-01Updated: 2019-12-04

Phase 3

Efficacy and Safety of Grazax in Children

CompletedNCT00408616

ALK-Abelló A/SAllergy

Start: 2006-11-30End: 2007-11-30Updated: 2009-03-09

Related Papers

Protocol for a randomised, double‐blind, placebo‐controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes

Clinical and Translational Allergy2015-01-014 citations